Benitec Biopharma Inc. financial statements
Benitec Biopharma Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2026
| Net income | −USD 45.55M | 10-K |
| Cash and equivalents | USD 179.97M | 10-Q |
Benitec Biopharma Inc. financials on 6ix · Benitec Biopharma Inc. on 6ix